Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 5/20 | 0.32 |
| ▸ | XDH | P47989 | 2/20 | 0.32 |
| ▸ | PI4KA | P42356 | 2/20 | 0.32 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.32 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.32 |
| ▸ | DRD3 | P35462 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | MKNK1 | Q9BUB5 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11591791 | 0.83 | HTT (0.33) | HTTCYP3A4LMNAXDHPI4KA | |
| SCHEMBL9116343 | 0.81 | HTT (0.32) | HTTCYP3A4LMNAXDHPI4KA | |
| SCHEMBL22892194 | 0.81 | CSNK2A1 (0.33) | PDPK1HTTCYP3A4LMNAXDH | |
| SCHEMBL160073 | 0.81 | CYP3A4 (0.35) | HTTCYP3A4LMNAXDHPI4KA | |
| SCHEMBL21913 | 0.81 | YTHDC1 (0.47) | PDPK1HTTCYP3A4LMNAXDH | |
| SCHEMBL4242949 | 0.81 | EGFR (0.33) | HTTCYP3A4LMNAXDHPI4KA | |
| SCHEMBL10918759 | 0.79 | YTHDC1 (0.46) | PDPK1HTTCYP3A4LMNAXDH | |
| SCHEMBL6272986 | 0.79 | YTHDC1 (0.46) | PDPK1HTTCYP3A4LMNAXDH | |
| SCHEMBL2938977 | 0.78 | MKNK1 (0.32) | HTTCYP3A4MKNK1 | |
| SCHEMBL405822 | 0.78 | PDPK1 (0.34) | PDPK1HTTCYP3A4LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119285636-A | Adenine-based iron ion chelating agent and synthesis and application thereof | 桂林医学院 | 2025-01-10 | — | — | CN | claimed |
| CN-117683071-A | Method for synthesizing aequorin and analogue thereof by microwave-assisted silica gel supported copper sulfate catalysis | 新乡学院 | 2024-03-12 | — | — | CN | claimed |
| CN-117430609-A | Purine derivative compound, preparation method and application thereof | 东北农业大学 | 2024-01-23 | — | — | CN | claimed |
| CN-115504978-B | Method for synthesizing adenine derivative by taking 6-hydrazinopurine derivative as raw material | 新乡学院 | 2023-08-25 | — | — | CN | claimed |
| CN-114773344-B | Method for synthesizing 2/6-iodopurine derivative through visible light induced hydrazine removal-iodination reaction | 新乡学院 | 2023-03-14 | — | — | CN | claimed |
| CN-115504978-A | Method for synthesizing adenine derivative by using 6-hydrazinopurine derivative as raw material | 新乡学院 | 2022-12-23 | — | — | CN | claimed |
| CN-114773344-A | Method for synthesizing 2/6-iodopurine derivative by visible light induced hydrazine removal-iodination reaction | 新乡学院 | 2022-07-22 | — | — | CN | claimed |
| CN-107884399-B | Purine compound modified nanogold material and kit thereof | 北京化工大学 | 2020-04-28 | — | — | CN | claimed |
| US-20150119351-A1 | THERAPY OF TUMORS AND INFECTIOUS AGENTS DEFICIENT IN METHYLTHIOADENOSINE PHOSPHORYLASE | LUBIN ADAM (US) | 2015-04-30 | — | — | US | claimed |
| US-8796241-B2 | Therapy of tumors and infectious agents deficient in methylthioadenosine phosphorylase | LUBIN ADAM (US) | 2014-08-05 | — | — | US | claimed |
| US-20120094947-A1 | METHOD FOR THE SELECTIVE THERAPY OF DISEASE | LUBIN ADAM (US) | 2012-04-19 | — | — | US | claimed |
| EP-2192905-A2 | METHOD FOR THE SELECTIVE THERAPY OF DISEASE | Lubin, Adam (US) | 2010-06-09 | — | — | EP | claimed |
| WO-2009032057-A2 | METHOD FOR THE SELECTIVE THERAPY OF DISEASE | LUBIN ADAM (US) | 2009-03-12 | — | — | WO | claimed |
| CN-121874799-A | Synthesis method of [1,2,4] -triazolone fused purine nucleoside compound | 河南师范大学 | 2026-04-17 | — | — | CN | disclosed |
| CN-118638119-B | Pyrazole purine herbicide safener as well as preparation method and application thereof | 东北农业大学 | 2025-02-28 | — | — | CN | disclosed |
| CN-119285636-A | Adenine-based iron ion chelating agent and synthesis and application thereof | 桂林医学院 | 2025-01-10 | — | — | CN | disclosed |
| US-4831013-A | BENZODIAZEPINE RECEPTOR ANTAGONISTS | CIBA-GEIGY CORPORATION (US) | 1989-05-16 | — | — | US | disclosed |
| WO-1988002370-A1 | 2-SUBSTITUTED-E-FUSED-[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINES PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | CIBA-GEIGY AG (CH) | 1988-04-07 | — | — | WO | disclosed |
| EP-0263071-A1 | 2-Substituted-e-fused-[1,2,4]-triazolo[1,5-c] pyrimidines, pharmaceutical compositions, and uses thereof | CIBA-GEIGY AG (CH) | 1988-04-06 | — | — | EP | disclosed |
| EP-0217748-A2 | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof | CIBA-GEIGY AG (CH) | 1987-04-08 | — | — | EP | disclosed |